<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:ns2="http://www.sec.gov/edgar/common">
    <headerData>
        <submissionType>144</submissionType>
        <filerInfo>
            <filer>
                <filerCredentials>
                    <cik>0001613084</cik>
                    <ccc>XXXXXXXX</ccc>
                </filerCredentials>
            </filer>
            <liveTestFlag>LIVE</liveTestFlag>



        </filerInfo>
    </headerData>
    <formData>
        <issuerInfo>
            <issuerCik>0001689375</issuerCik>
            <issuerName>ENTRADA THERAPEUTICS INC</issuerName>
            <secFileNumber>001-40969</secFileNumber>
            <issuerAddress>
                <ns2:street1>One Design Center Place, Suite 17-500</ns2:street1>
                <ns2:city>Boston</ns2:city>
                <ns2:stateOrCountry>MA</ns2:stateOrCountry>
                <ns2:zipCode>02210</ns2:zipCode>
            </issuerAddress>
            <issuerContactPhone>8575209158</issuerContactPhone>
            <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>DIPAL DOSHI</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
            <relationshipsToIssuer>
                <relationshipToIssuer>Director</relationshipToIssuer>
                <relationshipToIssuer>Officer</relationshipToIssuer>
            </relationshipsToIssuer>
        </issuerInfo>
        <securitiesInformation>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <brokerOrMarketmakerDetails>
                <name>Morgan Stanley Smith Barney LLC Executive Financial Services</name>
                <address>
                    <ns2:street1>1 New York Plaza</ns2:street1>
                    <ns2:street2>8th Floor</ns2:street2>
                    <ns2:city>New York</ns2:city>
                    <ns2:stateOrCountry>NY</ns2:stateOrCountry>
                    <ns2:zipCode>10004</ns2:zipCode>
                </address>
            </brokerOrMarketmakerDetails>
            <noOfUnitsSold>2000</noOfUnitsSold>
            <aggregateMarketValue>31760.00</aggregateMarketValue>
            <noOfUnitsOutstanding>33758976</noOfUnitsOutstanding>
            <approxSaleDate>06/13/2024</approxSaleDate>
            <securitiesExchangeName>NASDAQ</securitiesExchangeName>
        </securitiesInformation>
        <securitiesToBeSold>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <acquiredDate>01/13/2022</acquiredDate>
            <natureOfAcquisitionTransaction>Previously Exercised Stock Options</natureOfAcquisitionTransaction>
            <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
            <isGiftTransaction>N</isGiftTransaction>
            <amountOfSecuritiesAcquired>2000</amountOfSecuritiesAcquired>
            <paymentDate>01/13/2022</paymentDate>
            <natureOfPayment>Cash</natureOfPayment>
        </securitiesToBeSold>
        <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>10b5-1 Sales Plan for DIPAL DOSHI</name>
                <address>
                    <ns2:street1>One Design Center Place, Suite 17-500</ns2:street1>
                    <ns2:city>Boston</ns2:city>
                    <ns2:stateOrCountry>MA</ns2:stateOrCountry>
                    <ns2:zipCode>02210</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <saleDate>05/17/2024</saleDate>
            <amountOfSecuritiesSold>1200</amountOfSecuritiesSold>
            <grossProceeds>18129.12</grossProceeds>
        </securitiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>10b5-1 Sales Plan for DIPAL DOSHI</name>
                <address>
                    <ns2:street1>One Design Center Place, Suite 17-500</ns2:street1>
                    <ns2:city>Boston</ns2:city>
                    <ns2:stateOrCountry>MA</ns2:stateOrCountry>
                    <ns2:zipCode>02210</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <saleDate>05/16/2024</saleDate>
            <amountOfSecuritiesSold>1800</amountOfSecuritiesSold>
            <grossProceeds>27000.00</grossProceeds>
        </securitiesSoldInPast3Months>
        <noticeSignature>
            <noticeDate>06/13/2024</noticeDate>
            <planAdoptionDates>
                <planAdoptionDate>05/15/2023</planAdoptionDate>
            </planAdoptionDates>
            <signature>/s/ DIPAL DOSHI</signature>
        </noticeSignature>
    </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4845}]
144
0001613084
XXXXXXXX
LIVE
0001689375
ENTRADA THERAPEUTICS INC
001-40969
One Design Center Place, Suite 17-500
Boston
MA
02210
8575209158
DIPAL DOSHI
Director
Officer
Common
Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza
8th Floor
New York
NY
10004
2000
31760.00
33758976
06/13/2024
NASDAQ
Common
01/13/2022
Previously Exercised Stock Options
Issuer
N
2000
01/13/2022
Cash
N
10b5-1 Sales Plan for DIPAL DOSHI
One Design Center Place, Suite 17-500
Boston
MA
02210
Common
05/17/2024
1200
18129.12
10b5-1 Sales Plan for DIPAL DOSHI
One Design Center Place, Suite 17-500
Boston
MA
02210
Common
05/16/2024
1800
27000.00
06/13/2024
05/15/2023
/s/ DIPAL DOSHI